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ABSTRACT 
For any dosage forms enhancing dissolution is the first criteria i.e. it should give increased bioavailability in order to pr ovide onset of action. In 
market many poorly soluble drugs are available which are having problem of low solubility. Low solubility of these poorly water soluble drugs 
are the main issue factor in preparing dosage forms of these drugs as with low solubility enhanced or effective dissolution to reach therapeutic 
effect is difficult. To overcome these problems there are main engineering techniques came in market which helps in enhancing the dissolution 
of these drugs. Some of the common use techniques are cryogenic, super critical fluid technology, evaporative precipitation into aqueous 
solution, nano- milling methods were developed based on the drug properties and required nanoparticles character. Making use of these 
techniques has increases the in vitro dissolution rates and in vivo bioavailability of many poorly water soluble drugs. This review highlights 
about the materialistic availability of particle engineering processes recently reported in the literature for enhancing the dissolution properties 
of poorly water soluble drugs. 
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Introduction: 
Solubility is the quality of a solid, liquid, or gaseous chemical 
substance called solute to dissolve in a same substance of 
solvent to form a homogeneous solution of the solute in the 
solvent. The solubility of a substance basically depends on 
the solvent used at a particular temperature and pressure. 
The saturation concentration is measured as extent of 
solubility of a substance in a specific solvent where addition 
more solute will not increase its concentration in the 
solution. Solubility, permeability and dissolution are the 
three major factor that affects the bioavailability of drug1. 
Bioavailability of drug may be defined as the amount of drug 
that is absorbed from its site of administration and reaches 
in an unchanged form that is systemic circulation. These 
class II of drug which is poorly soluble drug majorly. BCS 
class of drug divided in to four categories-high solubility and 
high permeability, low solubility and high permeability, high 
solubility and low permeability, low solubility and low 
permeability. Increase in dissolution rate will increase the 
drug dissolution2. Increasing the surface area through 
particle size reduction of poorly soluble drugs results in poor 
bioavailability which Increases in dissolution rate. Poorly 
soluble drug makes the problem in bioavailability, under this 
circumstances solid dispersion method is mostly used. Solid 
dispersion technique is outlined because the dispersion of 1 
or a lot of active ingredient in associate degree inert carrier 
at solid state ready by melting, solvent, or melting solvent 
method. Solubility is the most important in pharmaceutical 
dosage form3. 
 Drug administered orally are more than 90% and having 
absorption, bioavailability and pharmacokinetic profile 
dependent on solubility parameter. Good dissolution and 
absorption indicates good solubility. Poorly soluble and 
dissolution are the main problems in pharmaceutical 
industry for designing a new dosage form. Many dissolution 
techniques are available for increasing solubility and 
permeability eg: coacervation, micronization, complexation 
solid dispersion and co-solvent4. Many manufacturing 
methods are available; fusion method, solvent evaporation 
method, hot melting extrusion, co-grinding method, 
supercritical method etc. The major problem for achieving 
good bioavailability is Aqueous solubility. To overcome this 
downside several ways has been investigate in drug 
development analysis5. 
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Crystal Engineering 
Crystal engineering is the exploitation of noncovalent 
interactions between molecular or ionic components for the 
rational design of solid-state structures that might show the 
interesting electrical, magnetic, and optical properties. It is 
also considered that it is becoming more evident that the, 
directionality, specificity and predictability of intermolecular 
hydrogen bonds can be used in combining the 
supramolecular structures of few controlled dimensionality6. 
Crystal has numerous ways to increase dissolution through 
crystallization method by preparing co crystals, high energy 
amorphous forms, metastable polymorphs and ultrafine 
particle. The development of co crystals and molecular 
complexs are important subside for salt formation, unlike of 
neutral compound or those having weakly ionizable groups. 
The sequence of dissolution of different solid forms is stable 
polymorphism is less than metastable and meta stable is less 
than amorphous7. 
 A. Supercritical Fluid Technology 
1.PGSS Process – Particles From Gas Saturated Solution: 
SCF acts as a solute in the PGSS method. The SC‐CO2 is 
compressed and dissolved in a molten polymer after 
autoclave treatment, where the solution expands and 
becomes cooled by the Joule‐ Thomson effect microparticles 
are formed when operated at a relatively low pressure. This 
approach is advantageous over other SCF techniques since it 
uses low volumes of SCF. However, the application of this 
process is limited due to particle agglomeration and nozzle 
blockage8. 
2.RESS Process- Rapid Expansion of Supercritical 
Solution: 
In a RESS process, SCF acts as a solute carrier, and this 
solution is expanded adiabatically leading to a quick drop in 
temperature and pressure and further generation of 
small‐sized particles after spraying through a nozzle. In 
scheming this process, the solubility of the material plays a 
crucial role in particle formation and sort out since most of 
the pharmaceutical substances such as polymers, drugs, and 
high‐molecular weight proteins are polar in nature9. In few 
instances, less amounts of organic solvents are added to 
improve the affinity of polar drug molecules. RESS is the 
simplest and an efficient method in the SCF technology, but it 
is limited in its application due its relatively high cost and 
poor solubility of polymers in non‐polar SC‐CO2. At 
industrial scales high amounts of SC‐CO2 are preferred to 
address this issue. To overcome certain limitations in further 
the evolution in the RESS process have been made. One of 
them is the RESS, method in an aqueous solution containing 
a surfactant or other reducing agents known as the rapid 
expansion of a supercritical solution into a liquid solvent 
(RESOLV) method, where the SCF is enlarge into a liquid 
medium10. This modified method stops the particle 
agglomeration in the expansion jet. The other modified 
methods in the rapid expansion of a supercritical solution 
with solid co‐solvent (RESS‐SC), which results in lesser‐sized 
particles. During synthesis, the added co‐solvent reinforce 
the solubility of the APIs to a greater extent by keeping away 
the superficial contact between particles, which increases the 
surface area of exposure to SCF and after some time, 
lyophilization can remove the co‐solvent. Despite its 
evolution, RESS still has certain curb that are surpassed by 
the altered SCF behavior as anti‐solvent in the reaction 
vessel11. 
3.SAS Process- Supercritical Anti-Solvent: 
The supercritical anti-solvent process is proposed to process 
the molecules with poor solubility in Supercritical fluid 
technology. This process predominantly utilizes an organic 
solvent such as acetone, dichloromethane, and dimethyl 
sulfoxide, to dissolve the materials, where Supercritical fluid 
technology behaves as a non‐solvent to solute. During the 
process, the mixture expands to supersaturation and results 
in fast nucleation, demonstrating the high mass transfer ratio 
due to the low viscosity and high diffusivity of Supercritical 
fluid technology12. The outcome of this process utterly 
depends on the order of addition of solvent, Supercritical 
fluid technology, and other substrates. Additionally, factors 
such as temperature, pressure, chemical composition of 
solute i.e. drug, polymer, as well as organic solvent are 
required to be optimized. Supercritical anti solvent has 
gained better drug loading than the rapid expansion of 
supercritical solution process, enabling the formation of fine 
particles. Other Supercritical anti solvent processes comprise 
of GAS, which is based on the recrystallization of SCF 
insoluble solute and has a flexibility of choosing organic 
solvent to improve the solubility13. This process has less 
operational problems compared to the conventional 
Supercritical anti solvent method and is easy to scale‐up in 
the manufacturing. Recent advancements in this method 
micronization techniques include, i.e., expanded liquid anti 
solvent and the supercritical‐assisted injection in a liquid 
anti‐ solvent methods. however, deep analyses on these 
processes yet remain to be reported. Expanded liquid anti 
solvent is operated using SCF and an organic solvent at 
expanding liquidity conditions. The other modified SAS 
techniques include ASES, SCF‐assisted extraction of 
emulsions (SFEE), SAS‐EM, SEDS, and SpEDS14. 
4.SEDS Process– Solution Enhanced Dispersion By 
Supercritical Fluids: 
SEDS is another important process of SAS technique 
operated at a lesser drying time and increased mass transfer 
rates, which decreases the ASES process curbs. In a 
distinctive SEDS process the scatter components are sprayed 
through a specially designed co‐axial nozzle to control the 
particle morphology. Mass transfer of SCF into the sprayed 
droplet represents the particle formation by the rate of 
solvent transfer into SCF phase15. A high mass transfer 
allows an increased nucleation and results in smaller particle 
sizes with less agglomeration. In fact, the polymer processing 
using organic solvents is highly available with this process 
due to of its solubility problems. Moreover, the repeated 
SEDS operation has increases the period of time of chemical 
compound materials. Water‐soluble compounds may be 
proscribed by mixing the organic solvent through a co‐axial 
three‐compartment nozzle16. 
5.Gas- Gas Antisolvent: 
Intensive mixture of poorly water soluble medicine 
resolution and carbon dioxide gas in giant vessel causes 
speedy nucleation of drug to make micronized drug particles. 
A Cottrell precipitator is partly crammed with the drug 
resolution then gas is introduced at very cheap to attain a 
more robust mixture17. Drawback of this system is that 
particle size and size distribution square measure tough to 
regulate. In most cases, mother liquor cannot be completely 
removed and additional drying processes are required. In 
spite of these drawbacks, several drugs and explosives were 
successfully processed in this manner18. 
B. Cryogenic Techniques 
Cryogenic techniques are developed to reinforce the 
dissolution rate of medication by making nanostructured 
amorphous drug particles with high degree of consistency at 
terribly low temperature conditions. Cryogenic inventions 
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were written by the kind of injection device capillary, rotary, 
pneumatic, and supersonic nozzle, location of nozzle (above 
or below the liquid level), and thus the composition of 
refrigerant liquid (hydrofluoroalkanes, N2, Ar, O2, and 
organic solvents). After refrigerant process, dry powder is 
obtained by varied drying processes like spray freeze drying, 
region freeze drying, vacuum freeze drying, and 
lyophilisation19. 
1.Spray Freezing onto Cryogenic Fluids: 
Briggs and Maxvell invented this method of spray freezing 
onto cryogenic fluids. In this method, the drug and therefore 
the carrier (maltose, inositol, lactose, mannitol or dextran) 
were dispersed in to water and pulverization top of the 
surface of a boiling ruffled halocarbon refrigerant. Sonication 
probe can be kept in the mixed refrigerant to reinforce the 
dispersion of the aqueous solution20. 
2.Ultra-Rapid Freezing (URF): 
Ultra-rapid phase transition could be a novel refrigerant 
technology that makes nanostructured drug particles with 
greatly increased expanse and desired surface morphology 
by victimization solid refrigerant substances. Application of 
medication resolution to the solid surface of refrigerant 
substrate results in instant phase transition and resulting 
drying up (for removal of solvent) forms micronized drug 
powder with improved solubility. Ultrafast phase transition 
hinders the section separation and therefore the 
crystallization of the pharmaceutical ingredients resulting in 
intimately mixed, amorphous drug-carrier solid dispersions, 
and solid solutions21. 
3.Spray Freezing into Vapor over Liquid (SFV/L): 
Freezing of drug solutions in refrigerant fluid vapours and 
resulting removal of frozen solvent produces fine drug 
particles with high wettability. During SFV/L the atomized 
droplets usually begin to freeze within the vapor section 
before they contact the refrigerant liquid. As the solvent 
freezes, the drug becomes concentrated within the 
liquescent regions of the atomized driblet, thus fine drug 
particles could nucleate and grow22. 
4.Spray Freezing into Cryogenic Liquids (SFL): 
The SFL particle engineering technology has been wont to 
turn out amorphous nanostructured aggregates of drug 
powder with high expanse and smart wettability. It 
incorporates direct liquid- liquid impingement between the 
automatized feed resolution and refrigerant liquid to 
produce intense atomization into microdroplets and 
consequently considerably quicker phase transition rates. 
The frozen particles square measure then preserved to get 
dry and free-flowing micronized powders23.  
C. Nanomilling 
Nanomilling is a higher to lower level approach for 
converting  large coarse particles into smaller, tiny particles. 
It is an inevitable in the application of mechanical energy to 
physically break down crystalline API structures. The main 
method used for nanomilling API is high energy media 
milling. This method is based on edge media—0.2-1 µm 
beads that are made from ceramics or highly cross linked 
polystyrene. The beads shear and collide with the API 
particles during the milling process, decreases their particle 
size24. During nanomilling, the API is suspended in an 
exceedingly resolution containing water and reduces the one 
of stabilizers to forestall reformation of particles over time. 
The nanomilling process provides an intermediate consisting 
of nanoparticles drap in to an aqueous vehicle. This is usually 
reflects as a nanoparticulate suspension.  Nanosuspensions 
are reproduced in to a good vary of dose forms, including 
oral liquids, capsules, tablets, films, injectables, aerosols, and 
more25. 
Conclusion 
Dissolution of drug is that the rate determinative step for 
oral absorption of the poorly water soluble medicine and 
solubility is that the basic demand for the absorption of the 
drug from scum bag. The various techniques represented on 
top of alone or together is went to enhance the solubility of 
the medicine. Proper choice of solubility enhancing 
methodology is that the key to make sure the goals of a 
decent formulation like good oral bioavailability, reduce 
frequency of dosing and higher patient compliance combined 
with a coffee price of production. Selection of methodology 
for solubility enhancing depends upon drug characteristics 
like solubility, chemical nature, freezing point, absorption 
pathway, physical nature, pharmacokinetic behavior so forth.  
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